The effects of beliefs regarding drug assignment in experimental and field studies of nicotine delivery devices: A review

Journal of Psychopharmacology

Volumn 28, Issue 11, 2014, Pages 1071-1079

  Dar, Reuven ^a   Barrett, Sean P ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

balanced placebo design; denicotinized cigarettes; Nicotine; nicotine replacement therapy; placebo; smoking

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; PLACEBO; TOBACCO SMOKE; NICOTINIC AGENT;

AEROSOL; ANXIETY; DRUG DELIVERY DEVICE; DRUG SELF ADMINISTRATION; HUMAN; INDEPENDENT VARIABLE; IRRITABILITY; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PLACEBO EFFECT; REVIEW; SHORT COURSE THERAPY; SMOKING; SMOKING CESSATION; ANIMAL; BEHAVIOR, ADDICTIVE; PSYCHOLOGY; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

ANIMALS; BEHAVIOR, ADDICTIVE; HUMANS; NICOTINE; NICOTINIC AGONISTS; PLACEBO EFFECT; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84907928702     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114548295     Document Type: Review

References (48)

1. Bailey SR, Fong DM, Bryson SW, et al. Perceived drug assignment and treatment outcome in smokers given nicotine patch therapy. J Subst Abuse Treat. 2010 ; 39: 150-156
2. Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: Randomised cross-over trial. Tob Control. 2010 ; 19: 98-103
3. Caine SB, Collins GT, Thomsen M, et al. Nicotine-like behavioral effects of the minor tobacco alkaloids nornicotine, anabasine, and anatabine in male rodents. Exp Clin Psychopharmacol. 2014 ; 22: 9-22
4. Clemens KJ, Caillé S, Stinus L, et al. The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. Int J Neuropsychopharmacol. 2009 ; 12: 1355-1366
5. Colagiuri B, Boakes R. Perceived treatment, feedback, and placebo effects in double-blind RCTs: An experimental analysis. Psychopharmacology. 2010 ; 208: 433-441
6. Correa JB, Heckman BW, Marquinez NS, et al. Perceived medication assignment during a placebo-controlled laboratory study of varenicline: Temporal associations of treatment expectancies with smoking-related outcomes. Psychopharmacology. 2014 ; 231: 2559-2566
7. Dar R, Stronguin F, Etter JF. Assigned versus perceived placebo effects in nicotine replacement therapy for smoking reduction in Swiss smokers. J Consult Clin Psychol. 2005 ; 73: 350-353
8. Darredeau C, Barrett SP. The role of nicotine content information in smokers' subjective responses to nicotine and placebo inhalers. Hum Psychopharmacol. 2010 ; 25: 577-581
9. Darredeau C, Stewart SH, Barrett SP. The effects of nicotine content information on subjective and behavioural responses to nicotine-containing and denicotinized cigarettes. Behav Pharmacol. 2013 ; 24: 291-297
10. Etter JF, Perneger T V. Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clin Pharmacol Ther. 2001 ; 69: 175-183
11. Etter JF, Laszlo E, Zellweger JP, et al. Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: A randomized trial. J Clin Psychopharmacol. 2002 ; 22: 487-495
12. Ferguson SG, Gitchell JG, Shiffman S. Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction. 2012 ; 107: 1349-1353
13. Fucito LM, Juliano LM. Effects of instructions on responses to the nicotine patch: a laboratory study. Psychopharmacology. 2007 ; 194: 475-483
14. Gottlieb AM, Killen JD, Marlatt GA, et al. Psychological and pharmacological influences in cigarette smoking withdrawal: Effects of nicotine gum and expectancy on smoking withdrawal symptoms and relapse. J Consult Clin Psychol. 1987 ; 55: 606-608
15. Hall BJ, Wells C, Allenby C, et al. Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats. Pharmacol Biochem Behav. 2014 ; 120: 103-108
16. Hammond D, McDonald PW, Fong GT, et al. Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour. Addiction. 2004 ; 99: 1042-1048
17. Harrell PT, Juliano LM. A direct test of the influence of response expectancies on the subjecitve and cognitive effects of smoking. Exp Clin Psychopharmacol. 2012 ; 20: 278-286
18. Hoffman AC, Evans SE. Abuse potential of non-nicotine tobacco smoke components: Acetaldehyde, nornicotine, cotinine, and anabasine. Nicotine Tob Res. 2013 ; 15: 622-632
19. Hughes JR, Krahn D. Blindness and the validity of the double-blind procedure. J Clin Psychopharmacol. 1985 ; 5: 138-142
20. Hughes JR, Gulliver SB, Amori G, et al. Effect of instructions and nicotine on smoking cessation, withdrawal symptoms and self-administration of nicotine gum. Psychopharmacology. 1989 ; 99: 486-491
21. Juliano LM, Brandon TH. Effects of nicotine dose, instructional set, and outcome expectancies on the subjective effects of smoking in the presence of a stressor. J Abnorm Psychol. 2002 ; 111: 88-97
22. Juliano LM, Brandon TH. Smoker' expectancies for nicotine replacement therapy vs smoking. Nicotine Tob Res. 2004 ; 6: 569-574
23. Juliano LM, Fucito LM, Harrell PT. The influence of nicotine dose and nicotine dose expectancy on the cognitive and subjective effects of cigarette smoking. Exp Clin Psychopharmacol. 2011 ; 19: 105-115
24. Kelemen WL, Kaighobadi F. Expectancy and pharmacology influence the subjective effects of nicotine in a balanced-placebo design. Exp Clin Psychopharmacol. 2007 ; 15: 93-101
25. Kirsch I How Expectancies Shape Experience. Kirsch I, ed. Washington, DC: American Psychological Association ; 1999: 3-13.
26. McRobbie H, Thornley S, Bullen C, et al. A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction. Addiction. 2010 ; 105: 1290-1298
27. Marlatt GA, Rohsenow DJ. Cognitive processes in alcohol use: Expectancy and the balanced placebo design. Adv Alcohol Subst Abuse. 1988 ; 1: 159-199
28. Mooney M, White T, Hatsukami D. The blind spot in the nicotine replacement therapy literature: Assessment of the double-blind in clinical trials. Addict Behav. 2004 ; 29: 673-684
29. Naqvi NH, Bechara A. The airway sensory impact of nicotine contributes to the conditioned reinforcing effects of individual puffs from cigarettes. Pharmacol Biochem Behav. 2005 ; 81: 821-829
30. Perkins KA, Fonte C, Meeker J, White W, Wilson A. The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pretreatment. Behav Pharmacol. 2001 ; 12: 35-44
31. Perkins K, Sayette M, Conklin C, et al. Placebo effects of tobacco smoking and other nicotine intake. Nicotine Tob Res. 2003 ; 5: 695-709
32. Perkins KA, Ciccocioppo M, Conklin CA, et al. Mood influences on acute smoking responses are independent of nicotine intake and dose expectancy. J Abnorm Psychol. 2008 ; 117: 79-93
33. Perkins KA, Grottenthaler A, Ciccocioppo MM, et al. Mood, nicotine, and dose expectancy effects on acute responses to nicotine spray. Nicotine Tob Res. 2009 ; 11: 540-546
34. Perkins KA, Jacobs L, Ciccocioppo M, et al. The influence of instructions and nicotine dose on the subjective and reinforcing effects of smoking. Exp Clin Psychopharmacol. 2004 ; 12: 91-101
35. Pickens W, Keenan M, Hughes JR, et al. Instructions control whether nicotine will serve as a reinforcer. J Pharmacol Exp Ther. 1985 ; 235: 106-112
36. Pritchard WS, Robinson JH, Guy TD, et al. Assessing the sensory role of nicotine in cigarette smoking. Psychopharmacology. 1996 ; 127: 55-62
37. Rose JE, Westman EC, Behm FM, et al. Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. Pharmacol Biochem Behav. 1999 ; 62: 165-172
38. Schlagintweit HE, Good KP, Barrett SP. The impact of nicotine lozenges and stimulus expectancies on cigarette craving. J Psychopharmacol. 2014 ; 28: 773-779
39. Schnoll RA, Patterson F, Wileyto EP, et al. Effectiveness of extended-duration transdermal nicotine therapy. Ann Intern Med. 2010 ; 152: 144-151
40. SilagyCLancasterTSteadL. (2004) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev3, Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000146.pub2/full (accessed 28 October 2013).
41. Sønderskov J, Olsen J, Sabroe S, et al. Nicotine patches in smoking cessation: A randomized trial among over-the-counter customers in Denmark. Am J Epidemiol. 1997 ; 145: 309-318
42. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012 ; 11: 1-194
43. Stepanov I, Jensen J, Hatsukami D, et al. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res. 2006 ; 8: 309-313
44. Stewart-Williams S, Podd J. The placebo effect: Dissolving the expectancy versus conditioning debate. Psychol Bull. 2004 ; 130: 324-340
45. Tønnesen P, Lauri H, Perfekt R, et al. Efficacy of a nicotine mouth spray in smoking cessation: A randomised, double-blind trial. Eur Respir J. 2012 ; 40: 548-554
46. How Tobacco Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, Georgia: USDHHS, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health ; 2010 :
47. Walsh R. Over-the-counter nicotine replacement therapy: A methodological review of the evidence supporting its effectiveness. Drug Alcohol Rev. 2008 ; 27: 529-547
48. Weimer K, Horing B, Stürmer J, et al. Nicotine stimulus expectancy differentially affects reaction time in healthy nonsmokers and smokers depending on sex: A pilot study. Exp Clin Psychopharmacol. 2013 ; 21: 181-187